Format

Send to

Choose Destination
J Med Chem. 1992 May 29;35(11):2103-12.

Renin inhibitors containing C-termini derived from mercaptoheterocycles.

Author information

1
Merck Sharp & Dohme Research Laboratories, Rahway, New Jersey 07065.

Abstract

A series of transition-state analogues having heterocyclythio C-termini has been synthesized and evaluated for inhibition of human renin. Addition of mercaptoheterocycles to a chiral Boc-amino epoxide intermediate led, after several steps, to the target [(2R,3S)-3-(BocPheHis-amino)-4-cyclohexyl-2-hydroxy-1-butyl]thio derivatives. Oxidation of the thioether to sulfone was also investigated. Several of the compounds, especially those derived from N1-substituted-5-mercaptotetrazoles or N4-substituted-3-mercapto-5-(trifluoromethyl)-1,2,4-triazoles, were moderately potent inhibitors of human plasma renin, having IC50 values of 30-40 nM. When selected compounds were administered intravenously to sodium-deficient rhesus monkeys at 0.3-1.2 mg/kg, they reduced plasma renin activity by 75-98%. However, this inhibition and the accompanying drop in blood pressure were of short duration.

PMID:
1597860
DOI:
10.1021/jm00089a023
[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center